文献速递系统性红斑狼疮其他结缔组织病

狼疮性肠炎:叙述性综述

Lupus enteritis: a narrative review.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

狼疮性肠炎(LE)是系统性红斑狼疮的罕见表现,病理生理机制尚未完全阐明,炎症与血栓形成过程可能是重要因素。诊断基于临床、组织病理学和影像学表现,腹部CT是诊断金标准。糖皮质激素常为一线治疗,免疫抑制治疗需个体化决定,因缺乏临床试验 defining 最佳治疗方案;出现肠穿孔或腹膜炎时可能需要手术干预。总体预后良好。

要点

  • 腹部CT是狼疮性肠炎诊断的金标准,并可识别预测并发症的因素。
  • 糖皮质激素常为一线治疗,免疫抑制治疗因无临床试验 defining 最佳方案而需个体化决定。
  • 及时识别并尽早开始治疗对避免危及生命和器官的并发症至关重要。

核心结论

  • 狼疮性肠炎是系统性红斑狼疮的罕见表现,总体预后良好,但需及时识别并尽早治疗以避免危及生命和器官的并发症。

主要发现

  • 超过半数狼疮性肠炎患者同时存在肾脏或血液系统并发症。
  • 腹部CT是狼疮性肠炎诊断的金标准,并可识别预测并发症的因素,可能指导药物和营养管理。
  • 糖皮质激素常为一线治疗,免疫抑制治疗等额外治疗因无临床试验定义最佳方案而需个体化决定。
  • 出现肠穿孔或腹膜炎时可能需要手术干预。

临床怎么用

  • 糖皮质激素常为狼疮性肠炎的一线治疗。
  • 免疫抑制治疗等额外治疗需根据个体情况决定,因无临床试验定义最佳治疗方案。
  • 出现肠穿孔或腹膜炎时可能需要手术干预。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lupus enteritis (LE) is a rare manifestation of systemic lupus erythematosus. The pathophysiology of LE has not been fully elucidated, although inflammatory and thrombotic processes are likely important factors. The underlying pathophysiological mechanisms may depend on which portion of the intestine is affected. Over half of the patients with LE also present with renal or haematological complications. The diagnosis of LE is based on clinical, histopathological and imaging findings; abdominal computed tomography (CT) is the gold standard in diagnosis. Abdominal CT can also identify factors that predict complications and could potentially guide pharmacological and nutritional management. Timely identification and prompt treatment initiation are paramount to avoid life and organ threatening complications. Glucocorticoids are often the first-line treatment. Additional therapy including immunosuppressive therapy is utilised on a case-by-case basis as there are no clinical trials to define the optimal therapeutic approach. Surgical intervention may be needed especially if there is bowel perforation or peritonitis. In general, the prognosis of LE is good.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Muñoz-Urbano M, Sangle S, D'Cruz DP, et al. Lupus enteritis: a narrative review. Rheumatology (Oxford). 2024. PMID: 38216993. doi:10.1093/rheumatology/kead689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。